Transthyretin Amyloidosis with Gastrointestinal Manifestation: a Case Report

Authors

  • Radislav Nakov Tsaritsa Yoanna University Hospital, Sofia, Bulgaria; Medical University of Sofia, Bulgaria
  • Stayko Sarafov Clinic of Nervous Diseases, Alexandrovska University Hospital, Sofia, Bulgaria
  • Ventsislav Nakov Tsaritsa Yoanna University Hospital, Sofia, Bulgaria; Medical University of Sofia, Bulgaria
  • Mariana Gospodinova Medical University of Sofia, Bulgaria; Clinic of Cardiology, Medical Institute of Ministry of Interior, Sofia, Bulgaria
  • Tihomir Todorov Genetic and Medico- diagnostic Laboratory “Genica”, Sofia, Bulgaria
  • Andrey Kirov Medical University of Sofia, Bulgaria; Genetic and Medico- diagnostic Laboratory “Genica”, Sofia, Bulgaria
  • Albena Todorova Medical University of Sofia, Bulgaria; Genetic and Medico- diagnostic Laboratory “Genica”, Sofia, Bulgaria
  • Ivailo Tournev Medical University of Sofia, Bulgaria; Clinic of Nervous Diseases, Alexandrovska University Hospital, Sofia, Bulgaria; Department of Cognitive Science and Psychology, New Bulgarian University, Sofia, Bulgaria

DOI:

https://doi.org/10.15403/jgld-422

Keywords:

transthyretin, amyloidosis, chronic diarrhea, misdiagnoses

Abstract

Transthyretin amyloidosis (ATTR) is a rare, progressive, life-threatening, hereditary disorder caused by mutations in the transthyretin gene. Due to the phenotypic heterogeneity, ATTR is difficult to recognize and it is often diagnosed very late. In ATTR gastrointestinal (GI) disorders play an important role in the patients’ morbidity and mortality. In some cases, GI symptoms are present even before the onset of the peripheral polyneuropathy. However, the complaints are various and it is really difficult to differentiate them from other GI disorders. We present a 61-year old male referred for diarrhea, unintentional weight loss and early satiety. He had hypotension after longstanding hypertension, numbness and tingling in the feet. We considered a broad differential diagnosis spectrum of chronic diarrhea syndrome and performed numerous laboratory, biochemical, imaging, endoscopic, histological and genetic tests. Transthyretin amyloidosis with a Glu89Gln mutation was diagnosed. Transthyretin amyloidosis is frequently misdiagnosed, representing a diagnostic challenge in GI practice. The presence of certain clinical combinations could help gastroenterologists to include ATTR in their diagnostic work-up.

Downloads

Published

2019-09-01

How to Cite

1.
Nakov R, Sarafov S, Nakov V, Gospodinova M, Todorov T, Kirov A, Todorova A, Tournev I. Transthyretin Amyloidosis with Gastrointestinal Manifestation: a Case Report. JGLD [Internet]. 2019 Sep. 1 [cited 2025 Jul. 1];28(3):359-61. Available from: https://www.jgld.ro/jgld/index.php/jgld/article/view/422

Issue

Section

Case Reports